The Uzbekistan market is one of the most important in the post-soviet states for the Pharmasyntez Group of Companies, since this country is characterized by a dynamically developing economy. I think that the decision of the Government of Uzbekistan on the development of the advanced pharmaceutical technology, is timely and correct. After all, it is not only the development of economic and industrial potential, but also ensuring the safety of drugs in the country and acquisition of technological skills. “As one of the largest pharmaceutical manufacturers in the Russian Federation, we are ready to invest in the construction of the pharmaceutical plant with the latest technologies, having the 25-year production experience. We are ready to implement a project under the mutual agreements”, - Nikita Punia, Executive Director of the Pharmasyntez GC, emphasized.

“This project will contribute in expanding of Pharmasyntez not only in the Uzbekistan market, but also in the neighboring countries”, - Sardor Kariev, Director of Pharmaceutical Agency, added.